Figure 4.

ACA reduces NF-κB activation in HSC-4 human oral cancer cells. (A) Reduction in IKK-α/β key phosphorylation sites prevents subsequent phosphorylation of IκB-α at Ser32/36, resulting in NF-κB inactivation. (B) All band intensities were quantified and normalized against β-actin using the ImageJ v1.43u software, and presented as mean ± SEM of three replicates.

In et al. BMC Complementary and Alternative Medicine 2012 12:179   doi:10.1186/1472-6882-12-179
Download authors' original image